PT Indofarma Persero, Tbk announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was IDR 583,537.509 million compared to IDR 739,172.949 million a year ago. Operating loss was IDR 12,871.050 million compared to IDR 9,332.935 million a year ago. Net loss was IDR 34,842.248 million compared to IDR 35,094.518 million a year ago. Basic loss per share was IDR 11.24 compared to IDR 11.32 a year ago.